Monoclonal Antibody Custom Service Market research report- Global forecast till 2023

Monoclonal Antibody Custom Service Market research report- Global forecast till 2023

ID: MRFR/HC/3098-CRR | October, 2017 | Region: Global | 85 pages | Cooked Research Reports

Global Monoclonal Antibody Custom Service Market Information: by type (rat custom monoclonal antibody, rabbit custom monoclonal antibody, others), by application (Diagnostic Application, Therapeutic Application, Protein Purification), by end users (hospitals, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies) - Global forecast till 2023 


Market Scenario


Monoclonal is a class of antibodies, which are derived from the identical offspring of a hybridomas. These antibodies can be grown indefinitely and are very specific for a particular location in the body derived from a single clone. Monoclonal antibodies recognize and bind to antigens to discriminate between specific epitopes, which provides protection against disease organisms. The specificity of MABs allow its binding to cancerous cells, which then seek outs to destroy the cancer cells. Monoclonal antibody custom service offers the selection of the developed rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provides a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies. The prices of custom antibody service depends on various factors such as type, titer and functional specifications of antibody produced. The pricing for custom monoclonal antibodies ranges from USD 3,500 to USD 11,500 per order.


Notably, increasing investment in the research & development is the key factor driving the monoclonal antibody custom service market. As per the report published in R&D magazine in 2016, total R&D expenditure was around USD 2.06 trillion. From the past few years, the China’s R&D investment is growing 10% per year and Asia accounts for over 42% of total R&D investments across the globe. Other factors such as, increasing prevalence of chronic diseases, infections, and rising occurrence of immunological diseases are also fueling the market growth. Rising demand for personalized medicine is also a vital factor responsible for the increasing development of therapeutic antibodies. However, high cost of the monoclonal antibody services may hinder the growth of the market over the forecast period. Monoclonal antibody has different applications, and one of its application, purification of antibody culture, costs around USD 1000.


It is estimated that monoclonal antibody custom service market is expected to grow at a CAGR of 10.84% during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical Companies

  • Biotechnology Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities 


Figure: Global monoclonal antibody custom service market, by type market share, 2016 (%)

Monoclonal Antibody Custom Service Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Segmentation


The global monoclonal antibody custom service market is segmented on the basis of type, application, and end-users.


On the basis of type, the market is segmented into rat custom monoclonal antibody, rabbit custom monoclonal antibody, and others.


On the basis of application, the market is classified into diagnostic application, therapeutic application, and protein purification. The diagnostic application is sub-segmented into biochemical analysis, and diagnostic imaging. The biochemical analysis is further segmented into pregnancy, cancer, hormonal disorder, and infectious diseases. The diagnostic imaging is further segmented into cardiovascular diseases, cancer, and bacterial infections. The therapeutic application is further segmented into MAb as therapeutic agents, MAb as targeting agents.


On the basis of end -users, the market is segmented into hospital, research & academic laboratories, pharmaceutical & biotechnology companies, and others.


Key Findings



  • The global monoclonal antibody custom service market is expected to reach USD 1,461.93 million by 2023 at a CAGR of 10.84%.

  • On the basis of type, rat custom monoclonal antibody market is expected to command the largest market share of 48.83% over the review period. However rabbit monoclonal antibody market is expected to grow at the fastest CAGR of 11.48% during the forecast period 2017-2023

  • The Americas hold the largest share of the monoclonal antibody custom service market and is expected to reach USD 523.77 million by 2023

  • Asia pacific is the fastest growing market, which is expected to grow at a CAGR of 11.47% over the 2017-2023


 


Regional Analysis


The Americas dominates the monoclonal antibody custom service market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. According to the National Cancer Institute in 2016, 1.6 million new cancer cases were diagnosed in the US.


Europe holds the second position in the monoclonal antibody custom service market. It is expected that the support provided by the government bodies for research & development drives the market in European region.


Asia-Pacific region is projected to be the fastest growing region during the forecast period. The high growth rate is due to increasing risk of infectious diseases in this region.


The Middle East and Africa holds the least share in the market owing to the presence of poor and slow developing countries, especially, in African region.


 


Key Players


Some of key the players in the market are Thermo Fisher Scientific, GenScript, Abnova Corporation, Creative-Biolabs, Abcam plc, ProMab Biotechnologies Inc, Envigo, and others.


Research Methodology

Monoclonal Antibody Custom Service Market-


Sources: Annual reports, Press release, White paper, and Company presentation


 





License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Scope of Study 15
2.2 Research Objective 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 15
2.4 Market Structure 16

3.1 Primary Research 18
3.2 Secondary Research 18
3.3 Market Size Estimation 18
3.3.1 Market share analysis 19
3.4 Market Pricing Approach 20

4.1 Introduction 21
4.2 Drivers 22
4.2.1 Increasing investment in research & development (weightage 45%) 22
4.2.2 Increasing prevalence of chronic diseases and infection (weightage 40%) 23
4.2.3 Increasing prevalence of immunological diseases (weightage 15%) 24
4.3 Restraints 25
4.3.1 High cost of the monoclonal antibody services 25
4.4 Opportunities 26
4.5 Macroeconomic Indicators 26

5.1 Value Chain Analysis 28
5.2 Porter’s Five Forces Model 29
5.2.1 Bargaining power of suppliers 29
5.2.2 Bargaining power of buyers 30
5.2.3 Threat of new entrants 30
5.2.4 Threat of substitutes 30
5.2.5 Intensity of rivalry 30
5.3 Investment Opportunity Analysis 31
5.4 Technology Trend Analysis 31

6.1 Introduction 32
6.2 Rat Custom Monoclonal Antibody 33
6.3 Rabbit Custom Monoclonal Antibody 35
6.4 Others 36

7.1 Introduction 37
7.2 Diagnostic Application 39
7.2.1 Biochemical Analysis 39
7.2.1.1 Pregnancy 39
7.2.1.2 Cancer 39
7.2.1.3 Hormonal Disorder 39
7.2.1.4 Infectious Diseases 40
7.2.2 Diagnostic Imaging 40
7.2.2.1 Cardiovascular Diseases 40
7.2.2.2 Cancer 41
7.2.2.3 Bacterial Infections 41
7.3 Therapeutic Application 42
7.3.1.1 MAb as Therapeutic Agents 42
7.3.1.2 MAb as Targeting Agents 42
7.4 Protein Purification 44

8.1 Introduction 45
8.2 Hospitals 47
8.3 Research & Academic Laboratories 48
8.4 Pharmaceutical & Biotechnology Companies 49

9.1 Introduction 50
9.2 Americas 52
9.2.1 US 55
9.2.2 Canada 57
9.2.3 South America 59
9.3 Europe 62
9.3.1 Germany 65
9.3.2 France 67
9.3.3 UK 69
9.3.4 Italy 71
9.3.5 Spain 73
9.3.6 Rest of Western Europe 75
9.3.7 Eastern Europe 77
9.4 Asia Pacific 80
9.4.1 Japan 83
9.4.2 China 85
9.4.3 India 87
9.4.4 Australia 89
9.4.5 Republic of Korea 91
9.4.6 Rest of Asia Pacific 93
9.5 Middle East & Africa 96
9.5.1 Middle East 99
9.5.2 Africa 101

10.1 Introduction 104
10.2 Company Share Analysis 104
10.3 Key Developments 105

11.1 Thermo Fisher Scientific 107
11.1.1 Company Overview 107
11.1.2 Financials 107
11.1.3 Products 107
11.1.4 Strategy 107
11.1.5 Key Developments 107
11.2 GenScript 108
11.2.1 Company Overview 108
11.2.2 Financials 108
11.2.3 Products 108
11.2.4 Strategy 108
11.2.5 Key Developments 108
11.3 Abnova Corporation 109
11.3.1 Company Overview 109
11.3.2 Financials 109
11.3.3 Products 109
11.3.4 Strategy 109
11.3.5 Key Developments 109
11.4 Creative-Biolabs 110
11.4.1 Company Overview 110
11.4.2 Financials 110
11.4.3 Products 110
11.4.4 Strategy 110
11.4.5 Key Developments 110
11.5 Abcam plc 111
11.5.1 Company Overview 111
11.5.2 Financials 111
11.5.3 Products 111
11.5.4 Strategy 111
11.5.5 Key Developments 111
11.6 ProMab Biotechnologies Inc 112
11.6.1 Company Overview 112
11.6.2 Financials 112
11.6.3 Products 112
11.6.4 Strategy 112
11.6.5 Key Developments 112
11.7 Envigo 113
11.7.1 Company Overview 113
11.7.2 Financials 113
11.7.3 Products 113
11.7.4 Strategy 113
11.7.5 Key Developments 113

12.1 Key Findings 114
12.1.1 CEO’s Viewpoint 114
12.1.2 Unmet Needs 114
12.1.3 Key Companies to Watch 114

13.1 Discussion Blue Print 115
13.2 References 117

TABLE 1 PRIMARY INTERVIEWS 19
TABLE 2 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE 2014-2023 (USD MILLION) 33
TABLE 3 GLOBAL RAT CUSTOM MONOCLONAL ANTIBODY MARKET, BY REGION 2014-2023 (USD MILLION) 34
TABLE 4 GLOBAL RABBIT CUSTOM MONOCLONAL ANTIBODY MARKET, BY REGION, 2014-2023 (USD MILLION) 35
TABLE 5 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION 2014-2023 (USD MILLION) 38
TABLE 6 GLOBAL DIAGNOSTIC APPLICATION MARKET, BY REGION 2014-2023 (USD MILLION) 41
TABLE 7 GLOBAL THERAPEUTIC APPLICATION MARKET, BY REGION 2014-2023 (USD MILLION) 43
TABLE 8 GLOBAL PROTEIN PURIFICATION MARKET, BY REGION, 2014-2023 (USD MILLION) 44
TABLE 9 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICEMARKET, END USER, BY REGION, 2014-2023 (USD MILLION) 46
TABLE 10 GLOBAL HOSPITALS MARKET, BY REGION, 2014-2023 (USD MILLION) 47
TABLE 11 GLOBAL RESEARCH & ACADEMIC LABORATORIES MARKET, BY REGION, 2014-2023 (USD MILLION) 48
TABLE 12 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2014-2023 (USD MILLION) 49
TABLE 13 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2014-2023 (USD MILLION) 51
TABLE 14 AMERICAS MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2014-2023 (USD MILLION) 53
TABLE 15 AMERICAS MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, TYPE, 2014-2023 (USD MILLION) 53
TABLE 16 AMERICAS MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, APPLICATION, 2014-2023 (USD MILLION) 54
TABLE 17 AMERICAS MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, END USER, 2014-2023 (USD MILLION) 55
TABLE 18 U.S. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, TYPE, 2014-2023 (USD MILLION) 55
TABLE 19 U.S. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, APPLICATION, 2014-2023 (USD MILLION) 56
TABLE 20 U.S. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, END USER, 2014-2023 (USD MILLION) 57
TABLE 21 CANADA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, TYPE, 2014-2023 (USD MILLION) 57
TABLE 22 CANADA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, APPLICATION, 2014-2023 (USD MILLION) 58
TABLE 23 CANADA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, END USER, 2014-2023 (USD MILLION) 59
TABLE 24 SOUTH AMERICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, TYPE, 2014-2023 (USD MILLION) 59
TABLE 25 SOUTH AMERICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, APPLICATION, 2014-2023 (USD MILLION) 60
TABLE 26 SOUTH AMERICA MONOCLONAL ANTIBODY CUSTOM SERVICEMARKET, END USER, 2014-2023 (USD MILLION) 61
TABLE 27 EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2014-2023 (USD MILLION) 63
TABLE 28 EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, TYPE, 2014-2023 (USD MILLION) 63
TABLE 29 EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, APPLICATION, 2014-2023 (USD MILLION) 64
TABLE 30 EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, END USER, 2014-2023 (USD MILLION) 65
TABLE 31 GERMANY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 65
TABLE 32 GERMANY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 66
TABLE 33 GERMANY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 67
TABLE 34 FRANCE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 67
TABLE 35 FRANCE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 68
TABLE 36 FRANCE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 69
TABLE 37 UK MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 69
TABLE 38 UK MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 70
TABLE 39 UK MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 71
TABLE 40 ITALY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 71
TABLE 41 ITALY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 72
TABLE 42 ITALY MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 73
TABLE 43 SPAIN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 73
TABLE 44 SPAIN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 74
TABLE 45 SPAIN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 75
TABLE 46 REST OF WESTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 75
TABLE 47 REST OF WESTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 76
TABLE 48 REST OF WESTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 77
TABLE 49 EASTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 77
TABLE 50 EASTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 78
TABLE 51 EASTERN EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 79
TABLE 52 ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2014-2023 (USD MILLION) 81
TABLE 53 ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 81
TABLE 54 ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 82
TABLE 55 ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 83
TABLE 56 JAPAN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 83
TABLE 57 JAPAN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 84
TABLE 58 JAPAN MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 85
TABLE 59 CHINA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 85
TABLE 60 CHINA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 86
TABLE 61 CHINA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 87
TABLE 62 INDIA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 87
TABLE 63 CHINA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 88
TABLE 64 CHINA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 89
TABLE 65 AUSTRALIA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 89
TABLE 66 AUSTRALIA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 90
TABLE 67 AUSTRALIA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 91
TABLE 68 REPUBLIC OF KOREA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 91
TABLE 69 REPUBLIC OF KOREA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 92
TABLE 70 REPUBLIC OF KOREA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 93
TABLE 71 REST OF ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 93
TABLE 72 REST OF ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 94
TABLE 73 REST OF ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 95
TABLE 74 MIDDLE EAST & AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2014-2023 (USD MILLION) 97
TABLE 75 MIDDLE EAST & AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 97
TABLE 76 MIDDLE EAST & AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 98
TABLE 77 MIDDLE EAST & AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 99
TABLE 78 MIDDLE EAST MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 99
TABLE 79 MIDDLE EAST MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 100
TABLE 80 MIDDLE EAST MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 101
TABLE 81 AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2014-2023 (USD MILLION) 101
TABLE 82 AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 102
TABLE 83 AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2014-2023 (USD MILLION) 103

FIGURE 1 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2016 (%) 12
FIGURE 2 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2016 (%) 12
FIGURE 3 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2016 (%) 13
FIGURE 4 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 (%) 14
FIGURE 5 GLOBAL MONOCLONAL ANTIBODIES CUSTOM SERVICES MARKET: MARKET STRUCTURE 16
FIGURE 6 RESEARCH PROCESS 17
FIGURE 7 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF THE GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET 21
FIGURE 8 VALUE CHAIN: CLINICAL DATA ANALYTICS MARKET 28
FIGURE 9 PORTERS FIVE FORCES MODEL 29
FIGURE 10 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY TYPE 2016 & 2023 (USD MILLION) 32
FIGURE 11 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION 2016 & 2023 (USD MILLION) 37
FIGURE 12 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET BY END USER, 2016 & 2023 (USD MILLION) 45
FIGURE 13 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 & 2023 (USD MILLION) 51
FIGURE 14 AMERICAS MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 (%) 52
FIGURE 15 EUROPE MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 (%) 62
FIGURE 16 ASIA PACIFIC MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 (%) 80
FIGURE 17 MIDDLE EAST & AFRICA MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET, BY REGION, 2016 (%) 96
FIGURE 18 GLOBAL MONOCLONAL ANTIBODY CUSTOM SERVICE COMPANY SHARE ANALYSIS, 2016 (%) 104